Zobrazeno 1 - 10
of 732
pro vyhledávání: '"Zhiyong MA"'
Publikováno v:
BMC Cancer, Vol 24, Iss 1, Pp 1-13 (2024)
Abstract Background Circular RNA (circRNAs) have been found to play major roles in the progression of colorectal cancer (CRC). However, the functions of circ_0008345 (transcribed by PTK2) in regulating CRC development remain undefined. In this study,
Externí odkaz:
https://doaj.org/article/581120e44d454e0c901aaf45a382ecf9
Autor:
Hao Hu, Shuyuan Pan, Zhiyong Ma, Kaiyi Liu, Yi Li, Haifeng Bao, Chengwei Deng, Fang Luo, Zehui Yang
Publikováno v:
SusMat, Vol 4, Iss 5, Pp n/a-n/a (2024)
Abstract The utilization of single atoms (SAs) as trifunctional electrocatalyst for nitrogen reduction, oxygen reduction, and oxygen evolution reactions (NRR, ORR, and OER) is still a formidable challenge. Herein, we devise one‐pot synthesized pall
Externí odkaz:
https://doaj.org/article/fef1f4d84fe74a8bb7df9353a0f8d304
Publikováno v:
BMJ Open, Vol 14, Iss 9 (2024)
Introduction Heart failure (HF) is a complex syndrome that affects millions of people worldwide and leads to significant morbidity and mortality. Sacubitril/valsartan, a combination drug consisting of a neprilysin inhibitor and an angiotensin recepto
Externí odkaz:
https://doaj.org/article/b0c6530eae7e4ef9b93c9c496a501471
Autor:
Xingliang Wu, Yewei Shen, Yu Xia, Yimin Luo, Sensen An, Kang Lei, Zhiyong Ma, Yanru Wang, Yaning Li, Xibo Jiang, Feiyang Xu, Sen Xu
Publikováno v:
Case Studies in Thermal Engineering, Vol 61, Iss , Pp 105024- (2024)
Nano aluminum powder effectively enhances reactivity, thereby improving energy-containing materials' performance. To investigate micro-nano self-assembled aluminum powders' energy output and their application in composite explosives, we tested the he
Externí odkaz:
https://doaj.org/article/0675e4e5c4f248ff973ac08bb173fdd3
Autor:
Mina Zhang, Guowei Zhang, Yuanyuan Niu, Guifang Zhang, Yinghua Ji, Xiangtao Yan, Xiaojuan Zhang, Qichuan Wang, Xiaohui Jing, Junsheng Wang, Zhiyong Ma, Huijuan Wang
Publikováno v:
Nature Communications, Vol 15, Iss 1, Pp 1-10 (2024)
Abstract This was a single-arm, multicenter phase 2 clinical trial (ChiCTR1900021726) involving advanced squamous non-small cell lung cancer (sq-NSCLC) patients undergoing 2 cycles of nab-paclitaxel/carboplatin and sintilimab (anti-PD-1), followed by
Externí odkaz:
https://doaj.org/article/baca36796b52474e9f55b7b00ed944b0
Autor:
Gen Lin, Zhijie Wang, Qian Chu, Yi Hu, Dingzhi Huang, Jun Wang, Fan Yang, Wenzhao Zhong, Chengzhi Zhou, Bo Zhu, Xinghao Ai, Baoshan Cao, Yabing Cao, Mingqiu Chen, Xiaohui Chen, Tianqing Chu, Jianchun Duan, Yun Fan, Yong Fang, Shuitu Feng, Weineng Feng, Hui Guo, Chengbo Han, Yong He, Shaodong Hong, Jie Hu, Meijuan Huang, Yan Huang, Da Jiang, Kan Jiang, Richeng Jiang, Bo Jin, Shi Jin, Jisheng Li, Min Li, Ziming Li, Chao Li, Jie Lin, Anwen Liu, Si‐Yang Maggie Liu, Liu Yutao, Zhefeng Liu, Zhe Liu, Zhenhua Liu, Zhentian Liu, Zhigang Liu, Yuping Lu, Tangfeng Lv, Zhiyong Ma, Qian Miao, Min Peng, Xingxiang Pu, Xiu Bao Ren, Jianzhen Shan, Jinlu Shan, Peng Shen, Bo Shen, Meiqi Shi, Yong Song, Zhengbo Song, ChunXia Su, Jianguo Sun, Panwen Tian, Jinliang Wang, Feng Wang, Huijuan Wang, Jialei Wang, Qian Wang, Wenxian Wang, Yan Wang, Lin Wu, Fang Wu, Yang Xia, Congying Xie, Conghua Xie, Tao Xin, Jianping Xiong, Haipeng Xu, Song Xu, Yiquan Xu, Bin Xu, Chunwei Xu, Xiaolong Yan, Zhenzhou Yang, Wenxiu Yao, Yao Yu, Ye Feng, Zongyang Yu, Yongfeng Yu, Dongsheng Yue, Haibo Zhang, HongMei Zhang, Li Zhang, Longfeng Zhang, Qiuyu Zhang, Tongmei Zhang, Bicheng Zhang, Jun Zhao, Mingfang Zhao, Xiaobin Zheng, Qiaofeng Zhong, Jin Zhou, Penghui Zhou, Zhengfei Zhu, Juntao Zou, Zihua Zou
Publikováno v:
Thoracic Cancer, Vol 15, Iss 5, Pp 419-426 (2024)
Abstract Immune checkpoint inhibitor (ICI) rechallenge in non‐small cell lung cancer (NSCLC) is a promising therapeutic strategy. The situation for ICI rechallenge can be divided into three categories: adverse events (AEs); resistance to ICIs, and
Externí odkaz:
https://doaj.org/article/5593cfcf22cf4de189ad661dbe843899
Publikováno v:
Frontiers in Pharmacology, Vol 15 (2024)
Chronic sinusitis is a common inflammatory disease of the nasal and sinus mucosa, leading to symptoms such as nasal congestion, runny nose, decreased sense of smell, and headache. It often recurs and seriously affects the quality of life of patients.
Externí odkaz:
https://doaj.org/article/fd182e01b22049a68567d2f1ac90494d
Autor:
Yafang Lin, Lujia Zhou, Changguang Xiao, Zongjie Li, Ke Liu, Beibei Li, Donghua Shao, Yafeng Qiu, Zhiyong Ma, Jianchao Wei
Publikováno v:
Frontiers in Microbiology, Vol 15 (2024)
IntroductionPorcine Reproductive and Respiratory Syndrome virus (PRRSV) causes high abortion rates in gestating sows and stillbirths, as well as high piglet mortality, seriously jeopardizing the pig industry in China and worldwide.MethodsIn this stud
Externí odkaz:
https://doaj.org/article/b8211e821c894329b1ca2459767d2dae
Autor:
Jianchun Duan, Wenfeng Fang, Hairong Xu, Jinliang Wang, Yuan Chen, Yi Ding, Xiaorong Dong, Yun Fan, Beili Gao, Jie Hu, Yan Huang, Cheng Huang, Dingzhi Huang, Wenhua Liang, Lizhu Lin, Hui Liu, Zhiyong Ma, Meiqi Shi, Yong Song, Chuanhao Tang, Jialei Wang, Lifeng Wang, Yongfeng Wang, Zhehai Wang, Nong Yang, Yu Yao, Yan Yu, Qitao Yu, Hongmei Zhang, Jun Zhao, Mingfang Zhao, Zhengfei Zhu, Xiaohui Niu, Li Zhang, Jie Wang
Publikováno v:
Journal of the National Cancer Center, Vol 3, Iss 4, Pp 256-265 (2023)
Lung cancer is the leading cause of cancer-related deaths worldwide. Bone is a common metastatic site of lung cancer, about 50% of bone metastatic patients will experience skeletal related events (SREs). SREs not only seriously impact the quality of
Externí odkaz:
https://doaj.org/article/64c371bf622d46b68856e83b202c08a9
Autor:
Dingzhi Huang, Gen Lin, Qian Chu, Yi Hu, Jun Wang, Zhijie Wang, Fan Yang, Wenzhao Zhong, Chengzhi Zhou, Bo Zhu, Xinghao Ai, Baoshan Cao, Yabing Cao, Mingqiu Chen, Xiaohui Chen, Tianqing Chu, Jianchun Duan, Yun Fan, Yong Fang, Shuitu Feng, Weineng Feng, Hui Guo, Chengbo Han, Yong He, Shaodong Hong, Jie Hu, Meijuan Huang, Yan Huang, Da Jiang, Kan Jiang, Richeng Jiang, Bo Jin, Shi Jin, Jisheng Li, Min Li, Ziming Li, Chao Li, Jie Lin, Anwen Liu, Si‐Yang Maggie Liu, Yutao Liu, Zhefeng Liu, Zhe Liu, Zhenhua Liu, Zhentian Liu, Zhigang Liu, Yuping Lu, Tangfeng Lv, Zhiyong Ma, Qian Miao, Min Peng, Xingxiang Pu, Xiu Bao Ren, Jianzhen Shan, Jinlu Shan, Peng Shen, Bo Shen, Meiqi Shi, Yong Song, Zhengbo Song, ChunXia Su, Jianguo Sun, Panwen Tian, Jinliang Wang, Feng Wang, Huijuan Wang, Jialei Wang, Qian Wang, Wenxian Wang, Yan Wang, Lin Wu, Fang Wu, Yang Xia, Congying Xie, Conghua Xie, Tao Xin, Jianping Xiong, Haipeng Xu, Song Xu, Yiquan Xu, Bin Xu, Chunwei Xu, Xiaolong Yan, Zhenzhou Yang, Wenxiu Yao, Yao Yu, Ye Feng, Zongyang Yu, Yongfeng Yu, Dongsheng Yue, Haibo Zhang, HongMei Zhang, Li Zhang, Longfeng Zhang, Qiuyu Zhang, Tongmei Zhang, Bicheng Zhang, Jun Zhao, Mingfang Zhao, Xiaobin Zheng, Fengqiao Zhong, Jin Zhou, Penghui Zhou, Zhengfei Zhu, Juntao Zou, Zihua Zou
Publikováno v:
Thoracic Cancer, Vol 14, Iss 34, Pp 3421-3429 (2023)
Abstract Immune checkpoint inhibitors (PD‐1/PD‐L1 and CTLA‐4 blockade) have revolutionized the treatment landscape in non‐small cell lung cancer (NSCLC). Secondary resistance to immunotherapy (IO), which poses a substantial challenge in clini
Externí odkaz:
https://doaj.org/article/bdd49d5369d24d70bad9a053f8310938